Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × Brentuximab Vedotin × 90 days × Clear all

Sponsor

Conditions

Hodgkin Disease 5 Mycosis Fungoides 2 Lymphoma 2 Squamous Cell Carcinoma of Head and Neck 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Melanoma 1 Lymphomatoid Papulosis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Primary Cutaneous Anaplastic Large Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Hematologic Diseases 1 Carcinoma, Non-Small-Cell Lung 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

venetoclax 42 Rituximab 25 obinutuzumab 22 ibrutinib 22 Cyclophosphamide 22 acalabrutinib 19 pirtobrutinib 17 fludarabine 17 Specimen Handling 11 zanubrutinib 10 fludarabine phosphate 10 Biopsy 10 Bendamustine Hydrochloride 10 Magnetic Resonance Spectroscopy 7 Whole-Body Irradiation 5 Prednisone 5 Lenalidomide 5 idelalisib 4 Vincristine 4 Mycophenolic Acid 4 Doxorubicin 4 CT-P10 4 ARQ531 4 pembrolizumab 3 Tacrolimus 3 tocilizumab 2 duvelisib 2 daratumumab 2 atezolizumab 2 Therapeutics 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡